Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating the safety and tolerability of maximal-use ruxolitinib cream in patients with Pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prurigo Nodularis

Drugs mentioned

• Ruxolitinib Cream (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Prurigo Nodularis | Phase 1 | Status: COMPLETED